{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=53", "query": { "intervention": "CTRL", "page": 53 }, "page_size": 10 }, "pagination": { "page": 53, "page_size": 10, "total_count": 26651, "total_pages": 2666, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=54&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=52&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T15:46:37.929Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01730040", "title": "Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Alirocumab", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 355, "start_date": "2012-10", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2015-08-31", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 56, "location_summary": "Mobile, Alabama • Chandler, Arizona • Tucson, Arizona + 53 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01730040" }, { "nct_id": "NCT07571889", "title": "Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain From onabotulinumtoxinA Injections" ], "interventions": [ { "name": "onabotulinumtoxinA prophylaxis with Lidocaine", "type": "PROCEDURE" }, { "name": "OnabotulinumtoxinA prophylaxis with Saline", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Association of Migraine Disorders", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 18, "start_date": "2026-03-03", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 1, "location_summary": "East Providence, Rhode Island", "locations": [ { "city": "East Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT07571889" }, { "nct_id": "NCT00628550", "title": "Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Cardiopulmonary Arrest", "Cardiac Arrest" ], "interventions": [ { "name": "Vasopressin", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "18 Years", "sex": "ALL", "summary": "Up to 18 Years" }, "enrollment_count": 130, "start_date": "2008-04", "completion_date": "2010-10", "has_results": false, "last_update_posted_date": "2019-09-17", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00628550" }, { "nct_id": "NCT00597818", "title": "Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "NSAID-induced Gastroduodenal Injury", "Ulcers", "Rheumatoid Arthritis", "Osteoarthritis" ], "interventions": [ { "name": "Cobiprostone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Non-steroidal anti-inflammatory drug", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sucampo Pharma Americas, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "40 Years to 70 Years" }, "enrollment_count": 121, "start_date": "2007-08", "completion_date": "2009-05", "has_results": true, "last_update_posted_date": "2019-12-26", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 19, "location_summary": "Phoenix, Arizona • Chula Vista, California • Loma Linda, California + 16 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Mission Hills", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00597818" }, { "nct_id": "NCT01131013", "title": "A Study of CK-2017357 in Patients With Peripheral Artery Disease and Symptomatic Claudication", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Intermittent Claudication", "Peripheral Artery Disease" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "375 mg CK-2017357", "type": "DRUG" }, { "name": "500 mg CK-2017357", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cytokinetics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 61, "start_date": "2010-05", "completion_date": "2011-03", "has_results": false, "last_update_posted_date": "2019-05-14", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 14, "location_summary": "Phoenix, Arizona • Santa Ana, California • Stanford, California + 11 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Santa Ana", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01131013" }, { "nct_id": "NCT01177813", "title": "Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Placebo identical to BI10773 high dose", "type": "DRUG" }, { "name": "BI 10773", "type": "DRUG" }, { "name": "BI 10773 open label", "type": "DRUG" }, { "name": "Placebo identical to BI10773 low dose", "type": "DRUG" }, { "name": "Placebo identical to Sitagliptin 100mg", "type": "DRUG" }, { "name": "BI10773", "type": "DRUG" }, { "name": "Sitagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 986, "start_date": "2010-07", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-16", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 27, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Hot Springs, Arkansas + 23 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Chino", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01177813" }, { "nct_id": "NCT04940624", "title": "A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dravet Syndrome (DS)" ], "interventions": [ { "name": "Soticlestat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "2 Years to 21 Years" }, "enrollment_count": 144, "start_date": "2021-10-28", "completion_date": "2024-04-11", "has_results": true, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 10, "location_summary": "Phoenix, Arizona • Los Angeles, California • San Francisco, California + 7 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Iowa City", "state": "Iowa" } ], "official_url": "https://clinicaltrials.gov/study/NCT04940624" }, { "nct_id": "NCT06634459", "title": "POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pelvic Organ Prolapse", "Prolapse" ], "interventions": [ { "name": "Reia System", "type": "DEVICE" }, { "name": "Standard of Care Pessary", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 218, "start_date": "2024-11-01", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-07-23", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Palo Alto, California • Washington D.C., District of Columbia + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Northbrook", "state": "Illinois" }, { "city": "Lebanon", "state": "New Hampshire" } ], "official_url": "https://clinicaltrials.gov/study/NCT06634459" }, { "nct_id": "NCT01138735", "title": "Epiduo Pediatric Acne Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acne" ], "interventions": [ { "name": "adapalene/benzoyl peroxide", "type": "DRUG" }, { "name": "Topical Gel Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "9 Years to 11 Years" }, "enrollment_count": 285, "start_date": "2010-06", "completion_date": "2011-08", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 20, "location_summary": "Birmingham, Alabama • San Diego, California • Santa Rosa, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Santa Rosa", "state": "California" }, { "city": "Miramar", "state": "Florida" }, { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01138735" }, { "nct_id": "NCT00041925", "title": "Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass Procedures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Peripheral Vascular Diseases", "Arterial Occlusive Diseases", "Ischemia", "Graft Occlusion, Vascular", "Hyperplasia" ], "interventions": [ { "name": "CGT003 (E2F Duplex Decoy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Anesiva, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1400, "start_date": "2001-11", "completion_date": "2004-11", "has_results": false, "last_update_posted_date": "2005-07-15", "last_synced_at": "2026-11-07T15:46:37.929Z", "location_count": 116, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Tucson, Arizona + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00041925" } ] }